CORRELATION OF ANTI-MÜLLERIAN HORMONE WITH LUTEINIZING HORMONE TO FOLLICLE STIMULATING HORMONE RATIO IN PATIENTS WITH SUSPECTED INFERTILITY
Abstract
Background: Anti-Müllerian Hormone (AMH) is produced by growing ovarian antral follicles. AMH is well correlated with the quantity of primordial follicles in the ovary. This study aimed to see any association of Anti-Müllerian Hormone with Leutinizing Hormone (LH) to Follicle Stimulating Hormone (FSH) ratio in patients suspected of infertility. Methods: It was a cross-sectional study performed in Department of Chemical Pathology/Biochemistry Laboratory Services of Liaquat National Hospital and Medical College Karachi from 1st April 2020 to 31st March 2021. Females aged of 18–50 years with suspected infertility were included. Women having other gynaecological diseases were excluded. Non-probability consecutive sampling was done. Blood was taken during the follicular phase of the menstrual cycle for estimation of AMH, FSH, and LH by Electrochemiluminescence Immunoassay. Data was analysed on SPSS-21. Mean and standard deviation were calculated, and Pearson’s correlation and One-way ANOVA was applied for variables. Result: A total of 103 patients were included in our study, out of which 62 (60%) had abnormal AMH and 41 (40%) had normal AMH levels. With abnormal AMH, we found a mild negative correlation with FSH and LH which are significant (p=0.001 and p=0.01 respectively). Regarding LH/FSH ratio, there was a mild positive and significant correlation with AMH (p=0.03). Conclusion: With low AMH levels, FSH and LH are increased and LH/FSH ratio is reduced. These findings can be used as markers of ovarian reserve in patients with infertility.
Pak J Physiol 2023;19(1):26–8
References
Abbara A, Eng PC, Phylactou M, Clarke SA, Hunjan T, Roberts R, et al. Anti-Müllerian Hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome. Frontiers in Endocrinology. 2019;10(656).
Kruszyńska K, Słowińska-Srzednicka J. Anti-Müllerian hormone (AMH) as a good predictor of time of menopause. Menopause Rev 2017;16(2):47-50.
Bednarska-Czerwin´ska A, Olszak-Wa˛sik A, Olejek A, Cerzerwi´nski M, Tukiendorf A. Vitamin D and Anti-Müllerian Hormone Levels in Infertility Treatment: The Change-Point Problem. Nutrients 2019;11:1053.
Saadullah SM, Sulaiman DM. Anti-Müllerian Hormone Level in Patients with Polycystic Ovary Syndrome. Med J Babylon. 2018;15:295-9.
Urrutia M, Grinspon RP, Rey RA. Comparing the role of anti-Müllerian hormone as a marker of FSH action in male and female fertility. Expert Review of Endocrinology & Metabolism 2019;14(3).
Segawa T, Omi K, Watanabe Y, Sone Y, Handa M, Kuroda M, et al. Age-specific values of Access anti-Müllerian hormone immunoassay carried out on Japanese patients with infertility: a retrospective large-scale study. BMC Women's Health. 2019;19(57).
Sun H, Maoa H, Cai J, Zhao Y. Research progress on anti-mullerian hormone clinical applications and immunoassay development. Frontiers in Laboratory Medicine. 2018;2:14-8.
van Houten ELAF, Themmen APN, Visser JA. Anti-Mullerian hormone (AMH): Regulator and marker of ovarian function. Annales d'Endocrinologie. 2010;71:191-7.
Yue CY, Lu LKY, Li M, Zhang QL, Ying CM. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women. PLOS ONE. 2018;https://doi.org/10.1371/journal.pone.0203129
Shembekar CA, Upadhye JJ, Shembekar MC, Welekar SH. Anti-Mullerian hormone (AMH) as predictor of ovarian reserve. Int J Reprod Contracept Obstet Gynecol. 2017;6(9):4006-10.
Lee JE, Yoon SH, Kim HO, Min EG. Correlation between the Serum Luteinizing Hormone to Follicle stimulating Hormone Ratio and the Anti-Müllerian Hormone Levels in Normo-ovulatory Women. J Korean Med Sci 2015;30:296-300.
Melado L, Lawrenz B, Sibal J, Abu E, Coughlan C, Navarro AT, et al. Anti-müllerian Hormone During Natural Cycle Presents Significant Intra and Intercycle Variations When Measured With Fully Automated Assay. Frontiers in Endocrinology. 2018;9 (Article 686).
Pasquali R. New perspectives on the role of anti-Müllerian hormone (AMH) in women. Ann Transl Med. 2018;6(Suppl 2):S94.
Barbakadze L, Kristesashvili J, Khonelidze N, Tsagareishvili G. The Correlations of Anti-Mullerian Hormone, Follicle-Stimulating Hormone and Antral Follicle Count in Different Age Groups of Infertile Women. International Journal of Fertility and Sterility. 2015;8(4):393-8.
Chung HJ, Park MH. Can AMH Level be Replaced by LH/FSH Ratio? Am J Clin Pathol. 2013;140(A036).
Jamil Z, Fatima SS, Ahmed K, Malik R. Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers. Hindawi Publishing Corporation Disease Markers. 2016;Article ID 5246217:9.
Safdarian L, Attar SNG, Aleyasin A, Aghahosseini M, Sarfjoo FS, Hosseinimousa S. Investigation of anti-mullerian hormone (AMH) level and ovarian response in infertile women with endometriosis in IVF cycles. Int J Reprod BioMed. 2018;16(11):719-22.
Le MT, Le VNS, Le DD, Nguyen VQH, Chen C, Cao NT. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome. Clinical Endocrinology. 2019;90:579-85.
Chen YP, Wu WH, Wu HM, Chen CK, Wang HS, Huang HY. Effects of anti-Müllerian hormone and follicle stimulating hormone levels on in vitro fertilization pregnancy rate. Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 313e316. 2014;53:313-6.
Downloads
Copyright (c) 2023 Pakistan Journal of Physiology
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Pakistan Journal of Physiology, Pak J Physiol, PJP is FREE for research and academic purposes. It can be freely downloaded and stored, printed, presented, cited and quoted with full reference of, and acknowledgement to the PJP.
